Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Rapt Therapeutics Inc
(NQ:
RAPT
)
2.300
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Rapt Therapeutics Inc
< Previous
1
2
3
4
5
Next >
RAPT Therapeutics Strengthens Leadership Team with Two New Key Hires
September 28, 2022
From
RAPT Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 24, 2022
Gainers Aridis Pharmaceuticals (NASDAQ:ARDS) shares moved upwards by 20.1% to $1.79 during Wednesday's after-market session. The market value of their outstanding shares is at $31.6 million.
Via
Benzinga
HC Wainwright & Co. Maintains Buy Rating for RAPT Therapeutics: Here's What You Need To Know
August 12, 2022
HC Wainwright & Co. has decided to maintain its Buy rating of RAPT Therapeutics (NASDAQ:RAPT) and raise its price target from $50.00 to $53.00. Shares of RAPT Therapeutics are trading up 14.98% over...
Via
Benzinga
LegalZoom.com, Toast And Some Other Big Stocks Moving Higher On Friday
August 12, 2022
WeTrade Group, Inc. (NASDAQ: WETG) jumped 46% to $20.56 after the company announced it entered into a sales agreement with Parkway Medical Limited to sell monkeypox virus test kits and antigen tests...
Via
Benzinga
Expert Ratings For RAPT Therapeutics
August 12, 2022
RAPT Therapeutics (NASDAQ:RAPT) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Recap: RAPT Therapeutics Q2 Earnings
August 11, 2022
RAPT Therapeutics (NASDAQ:RAPT) reported its Q2 earnings results on Thursday, August 11, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday
August 15, 2022
Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results.
Via
Benzinga
This Mid-Cap Firm Can Potentially Offer Biggest Oral Drug In Atopic Dermatitis, Cantor Thinks So
May 25, 2022
Via
Benzinga
Recap: RAPT Therapeutics Q1 Earnings
May 11, 2022
RAPT Therapeutics (NASDAQ:RAPT) reported its Q1 earnings results on Wednesday, May 11, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday's Mid-Day Session
August 12, 2022
Gainers Twin Vee Powercats Co. (NASDAQ: VEEE) shares jumped 90% to $7.60 after the company said Q2 sales results were up year over year.
Via
Benzinga
This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday
July 29, 2022
Gainers Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11,...
Via
Benzinga
What 4 Analyst Ratings Have To Say About RAPT Therapeutics
May 24, 2022
Analysts have provided the following ratings for RAPT Therapeutics (NASDAQ:RAPT) within the last quarter:
Via
Benzinga
Starbucks And 2 Other Stocks Insiders Are Buying
May 13, 2022
Although the Dow Jones jumped by more than 400 points on Friday, there were a few notable insider trades.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
May 04, 2022
During Wednesday's trading, 435 companies set new 52-week lows.
Via
Benzinga
RAPT Therapeutics's Return On Capital Employed Insights
March 14, 2022
According to Benzinga Pro data, during Q4, RAPT Therapeutics (NASDAQ:RAPT) posted sales of $756.00 thousand. Earnings were up 3.87%, but RAPT Therapeutics still reported an...
Via
Benzinga
RAPT Therapeutics: Q4 Earnings Insights
March 10, 2022
RAPT Therapeutics (NASDAQ:RAPT) reported its Q4 earnings results on Thursday, March 10, 2022 at 08:00 AM. Here's what investors need to know about the announcement....
Via
Benzinga
65 Biggest Movers From Yesterday
January 19, 2022
Gainers Brickell Biotech, Inc. (NASDAQ: BBI) shares jumped 58.6% to settle at $0.33 on Tuesday after HC Wainwright & Co initiated coverage on the stock with a Buy rating and...
Via
Benzinga
60 Biggest Movers From Yesterday
January 11, 2022
Gainers Bone Biologics Corporation (NASDAQ: BBLG) shares surged 57.1% to close at $5.39 on Monday. Zynga Inc. (NASDAQ: ZNGA) rose 40.7% to settle at $8.44 after the company...
Via
Benzinga
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
November 03, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Horizon Announces Retirement Of CFO, Beat-and-raise Q3 Horizon Therapeutics...
Via
Benzinga
Topics
Retirement
Exposures
Pension
Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021
December 09, 2021
Upgrades According to BMO Capital, the prior rating for Nuvei Corp (NASDAQ:
Via
Benzinga
How Good Are RAPT Therapeutics's Earnings? | Return On Capital Employed
September 28, 2021
According to Benzinga Pro data, during Q2, RAPT Therapeutics (NASDAQ:RAPT) posted sales of $869.00 thousand. Earnings were up 2.9%, but RAPT Therapeutics still reported an overall...
Via
Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...
Via
Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc. (...
Via
Benzinga
Exposures
COVID-19
Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2021
August 12, 2021
Upgrades According to Northland Capital Markets, the prior rating for Points International Ltd
Via
Benzinga
10 Biggest Price Target Changes For Wednesday
June 23, 2021
Wedbush boosted Microsoft Corporation (NASDAQ: MSFT) price target from $310 to $325. Microsoft shares slipped 0.1% to $265.48 in pre-market trading. Morgan Stanley boosted...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2021
June 21, 2021
Upgrades B of A Securities upgraded the previous rating for Cimarex Energy Co (NYSE:
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
June 21, 2021
Gainers MediciNova (NASDAQ:MNOV) shares moved upwards by 50.79% to $5.67 during Monday's pre-market session. The market value of their outstanding shares is at $276.5...
Via
Benzinga
The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO
June 16, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 15) Apellis Pharmaceuticals,...
Via
Benzinga
Exposures
COVID-19
Product Safety
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 16, 2021
Gainers Kindred Biosciences (NASDAQ:KIN) shares moved upwards by 45.26% to $9.21 during Wednesday's pre-market session. The market value of their outstanding shares is...
Via
Benzinga
RAPT Therapeutics Raises $125M Via Equity At 6% Discount
June 16, 2021
RAPT Therapeutics Inc (NASDAQ: RAPT) has priced its previously announced underwritten public offering of 3.8 million shares at $33/share. The price represents a 6...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.